Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, cilt.37, sa.4, ss.236-240, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 37 Sayı: 4
- Basım Tarihi: 2021
- Doi Numarası: 10.1089/jop.2020.0081
- Dergi Adı: JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CAB Abstracts, Chemical Abstracts Core, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.236-240
- Anahtar Kelimeler: adalimumab, infliximab, noninfectious, pediatric, uveitis
- Bursa Uludağ Üniversitesi Adresli: Evet
Özet
Purpose: Management of uveitis displays a particular challenge in childhood. This study aims to compare the efficacy and safety of infliximab (IFX) and adalimumab (ADA) in pediatric noninfectious uveitis that were refractory to conventional immunosuppresives.